| Management number | 233410998 | Release Date | 2026/06/27 | List Price | US$83.13 | Model Number | 233410998 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Cyclic nucleotide phosphodiesterases (PDEs) are promising targets for pharmacological intervention. Multiple PDE genes, isoform diversity, selective expression and compartmentation of the isoforms, and an array of conformations of PDE proteins are properties that challenge development of drugs that selectively target this class of enzymes. Novel characteristics of PDEs are viewed as unique opportunities to increase specificity and selectivity when designing novel compounds for certain therapeutic indications. This chapter provides a summary of the major concepts related to the design and use of PDE inhibitors. Read more
| ASIN | B00F773MZQ |
|---|---|
| XRay | Not Enabled |
| ISBN13 | 978-3642179693 |
| Edition | 2011th |
| Language | English |
| File size | 6.2 MB |
| Page Flip | Enabled |
| Publisher | Springer |
| Word Wise | Not Enabled |
| Print length | 538 pages |
| Accessibility | Learn more |
| Part of series | Handbook of Experimental Pharmacology |
| Publication date | June 21, 2011 |
| Enhanced typesetting | Enabled |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form